SocIal ROBOTics for Active and Healthy Ageing (SI-ROBOTICS)

The study was designed to test the acceptability of the Si-Robotics system in a group of 20 subjects with Parkinson's Disease at an early stage, during a rehabilitation treatment based on Irish dancing. Assessments will be performed at the baseline and at the end of the treatment.

Study Overview

Detailed Description

The study was designed to test the acceptability of the SI-ROBOTICS system in a group of 20 subjects with Parkinson's Disease at an early stage during a rehabilitation treatment.

The SI-ROBOTICS system is composed of multiple technological components with the aim of facilitating a rehabilitation program based on Irish dance and encouraging the execution of dance steps. The SI-ROBOTICS system consists of:

  • ROBOTIC PLATFORM: a social robot that allows the monitoring of patients during sessions, moving around patients safely and, if necessary, intervening in their support.
  • LET'S DANCE GAME: a component that allows users to enjoy the game sessions (setting up of therapy sessions by the therapist, presentation of tasks to the player and execution by the latter, display of feedback on the sessions).
  • ENVIRONMENTAL AND WEARABLE SENSORS: this allows data to be collected on the patient's main clinical parameters (e.g. heart rate, respiratory rate, etc.). These data allow the therapist to know the patient's state during the execution of tasks and the AI reasoner component to have an additional level of information with which to adapt the planning of steps.
  • AI REASONERS: this is the back-end of the Si-Robotics system, i.e. the "intelligent" component that allows the adaptation of the game sessions, based on the users' game performance and the data collected through the sensors. In this way it will be possible to dynamically customize the session according to the user's needs and abilities.
  • ARTIFICIAL VISION SETTING: a commercial camera called Inter Real Sense (https://www.intel.it/content/www/it/it/architecture-and-technology/realsense-overview.html) will be installed in the experimental setting for the extraction of kinematic parameters, saved anonymously and locally on this computer. Also the robotic platform will be equipped with a RealSense camera and will be able to acquire kinematic parameters. To extract features of interest from the signals, proprietary skeleton tracking software of the Real Sense camera will be used, together with specially developed algorithms for feature extraction.

In addition, kinematic and performance parameters will be collected, which will be used by the physiotherapist to evaluate and plan subsequent sessions, and by the system to delineate the levels of difficulty of the exercise.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Ancona, Italy
        • Recruiting
        • IRCCS INRCA Hospital
        • Principal Investigator:
          • Giovanni Riccardi
        • Contact:
      • Ancona, Italy, 60127
        • Not yet recruiting
        • IRCCS INRCA Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Capacity to consent;
  • Hoen and Yahr scale: 1-2 stage;
  • Functional Ambulation Category (FAC) ≥ 2;
  • Ranking scale score ≤ 3;
  • Stability of drug treatment for at least 1 month;
  • Geriatric Depression Scale 4-items ≤ 1;
  • Mini Mental State Examination ≥ 24;
  • Maintaining an upright posture ≥ 30''.

Exclusion Criteria:

  • History of syncopal episodes, epilepsy and vertigo not controlled pharmacologically;
  • Serious dysfunction of the autonomic system;
  • Severe behavioral syndromes not compensated by drugs;
  • Concurrent neurological and/or cardiac diseases;
  • Recent femur fracture
  • Chronic medium to severe pain affecting standing or walking.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rehabilitation Group
PD subjects will be going through a rehabilitation program based on an Irish dance with the support of the technological platform SI-ROBOTICS

A 16-treatment session will be conducted, divided into 2 training sessions per week, for 8 weeks. The therapy sessions last 60 minutes; each session will involve 2 patients at time. Cardiac and respiratory activity monitoring is planned during robotic treatments in order to detect the heart rate during physical activity. Individual participants must complete at least 80% of the sessions. Recovery of 2 sessions will be possible.

Each session involves the following activities:

  • Breathing, relaxation and postural harmonization exercises;
  • Active mobility and stretching exercises;
  • Irish dance with the SI-ROBOTICS system;
  • Relaxation exercises.
Other Names:
  • SI-ROBOTICS a technological system facilitating a rehabilitation program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in acceptability of the SI-ROBOTICS system
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement

Acceptability will be assessed using a 52-item questionnaire based on the unified theory of acceptance and use of technology (UTAUT) model. It's a standardized instrument for measuring the likelihood of success for new technology introductions and helps to understand the drivers of its acceptance.

The questionnaire has 52 questions distributed in 4 key constructs: 1) performance expectancy, 2) effort expectancy, 3) social influence, and 4) facilitating conditions.

Each question are based on a Likert-type 5-point scale ranging from 1 = strongly disagree to 5 = strongly agree. Increments are integers between 1 to 5.

change from baseline to 4 and 8 weeks after intervention commencement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in walking speed
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement
The walking speed will be evaluated by the Six-Minute Walking Test (6MWT).
change from baseline to 4 and 8 weeks after intervention commencement
Change in balance
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement
The change in balance will be evaluated by the Performance-Oriented Mobility Assessment (POMA) consists of two sub-scales: the balance evaluation scale ("balance scale" or POMA-B) and the gait evaluation scale ("gait scale" or POMA-G). The maximum score is 28 points: in detail, the maximum score of the POMA-B is 16, while for the POMA-G the maximum score is 12.
change from baseline to 4 and 8 weeks after intervention commencement
Change in fear of falling
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement
The change in fear of falling will be evaluated by the Short Falls Efficacy Scale - International (FES-I- Short). The cut offs are divided as follows: a score between 7-8 indicates a low concern, between 9-12 a moderate concern and between 14 and 28, high concern.
change from baseline to 4 and 8 weeks after intervention commencement
Change in physical performance
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement
Change in physical performance will be ascertained using the Short Physical Performance Battery (SPPB). Summary scores range from 0-12 and higher scores denote higher physical performance
change from baseline to 4 and 8 weeks after intervention commencement
Change in mobility
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement
Change in mobility will be evaluated by Timed-Up-and-Go (TUG) Test. A score of ten seconds or less indicates normal mobility; times between 11 and 20 seconds are within normal limits for frail elderly and disabled patients; times over 20 seconds indicate that the person requires external assistance and the need for further examination and intervention. A score above 30 seconds suggests that the person may be prone to falls.
change from baseline to 4 and 8 weeks after intervention commencement
Change in goal attainment scale
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement
Change in goal attainment scale (GAS): definition of an individual goal at start, followed by a 6- point numeric scale indicating to what extent the goal is (score 0 till +2) or is not (-3 indicating detoriation till -1) reached.
change from baseline to 4 and 8 weeks after intervention commencement
Change in quality of life
Time Frame: change from baseline to 4 and 8 weeks after intervention commencement
SF-12 Health Survey (SF-12) is composed of 12 items that produce two measurements related to two different aspects of health: physical health and mental health.
change from baseline to 4 and 8 weeks after intervention commencement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giovanni Riccardi, MD, IRCCS-INRCA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 19, 2022

Primary Completion (Estimated)

March 29, 2024

Study Completion (Estimated)

March 29, 2024

Study Registration Dates

First Submitted

August 5, 2021

First Submitted That Met QC Criteria

August 5, 2021

First Posted (Actual)

August 13, 2021

Study Record Updates

Last Update Posted (Actual)

October 23, 2023

Last Update Submitted That Met QC Criteria

October 20, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be available to other researchers following a documented request to the INRCA investigators.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on rehabilitation program with the support of the technological platform SI-ROBOTICS

3
Subscribe